171 related articles for article (PubMed ID: 12722741)
21. Clinical experience with 99mTc-hexamethylpropylene-amineoxime for labelling leucocytes and imaging inflammation.
Peters AM; Danpure HJ; Osman S; Hawker RJ; Henderson BL; Hodgson HJ; Kelly JD; Neirinckx RD; Lavender JP
Lancet; 1986 Oct; 2(8513):946-9. PubMed ID: 2877132
[TBL] [Abstract][Full Text] [Related]
22. Nuclear medicine and infection detection: the relative effectiveness of imaging with 111In-oxine-, 99mTc-HMPAO-, and 99mTc-stannous fluoride colloid-labeled leukocytes and with 67Ga-citrate.
Hughes DK
J Nucl Med Technol; 2003 Dec; 31(4):196-201; quiz 203-4. PubMed ID: 14657285
[TBL] [Abstract][Full Text] [Related]
23. In vitro assessment of cytotoxicity and labeling efficiency of 99mTc-HMPAO with stromal vascular fraction of adipose tissue.
Verma VK; Beevi SS; Tabassum A; Kumaresan K; Kamaraju RS; Arbab AS; Chelluri LK
Nucl Med Biol; 2014 Oct; 41(9):744-8. PubMed ID: 25037755
[TBL] [Abstract][Full Text] [Related]
24. Uptake of technetium-99m hexamethylpropylene amine oxime labelled white cells in lymph nodes involved in non-Hodgkin's lymphoma.
AL-Nahhas AM; Hjiyiannakis P; Hammersley PA; McCready VR; Horwich AH
Eur J Nucl Med; 1995 Dec; 22(12):1453-6. PubMed ID: 8586091
[TBL] [Abstract][Full Text] [Related]
25. Imaging of abdominal infection using 99m Tc stannous fluoride colloid labelled leukocytes.
Carter NJ; Eustance CN; Barrington SF; O'Doherty MJ; Coakley AJ
Nucl Med Commun; 2002 Feb; 23(2):153-60. PubMed ID: 11891469
[TBL] [Abstract][Full Text] [Related]
26. Different uptake of 99mTc-ECD adn 99mTc-HMPAO in the same brains: analysis by statistical parametric mapping.
Hyun Y; Lee JS; Rha JH; Lee IK; Ha CK; Lee DS
Eur J Nucl Med; 2001 Feb; 28(2):191-7. PubMed ID: 11303889
[TBL] [Abstract][Full Text] [Related]
27. Biological consequences of the heterogeneous irradiation of lymphocytes during technetium-99m hexamethylpropylene amine oxime white blood cell labelling.
de Labriolle-Vaylet C; Colas-Linhart N; Sala-Trepat M; Petiet A; Voisin P; Bok B
Eur J Nucl Med; 1998 Oct; 25(10):1423-8. PubMed ID: 9818283
[TBL] [Abstract][Full Text] [Related]
28. Use of technetium-99m HMPAO scintigraphy for the detection of amiodarone lung toxicity in a rabbit model.
Capa Kaya G; Bekis R; Kirimca F; Ertay T; Kargi A; Gure A; Durak H
Eur J Nucl Med; 2001 Mar; 28(3):346-50. PubMed ID: 11315603
[TBL] [Abstract][Full Text] [Related]
29. Radiolabelling of human platelets with 99mTc-HMPAO.
Vorne M; Honkanen T; Karppinen K; Röning M; Sakki S
Eur J Haematol; 1989 May; 42(5):487-91. PubMed ID: 2731595
[TBL] [Abstract][Full Text] [Related]
30. [In vitro and in vivo studies using 111 indium oxine, 111 indium oxine sulfate and 99m Tc oxine in erythrocyte labeling].
Reiter S; Angelberger P; Kolbe H; Sinzinger H
Wien Klin Wochenschr; 1984 Feb; 96(3):120-3. PubMed ID: 6426172
[TBL] [Abstract][Full Text] [Related]
31. Biodistribution and radiation dosimetry of 99mTc-HMPAO-labeled monocytes in patients with rheumatoid arthritis.
Bennink RJ; Thurlings RM; van Hemert FJ; Voermans C; Dohmen SE; van Eck-Smit BL; Tak PP; Busemann-Sokole E
J Nucl Med; 2008 Aug; 49(8):1380-5. PubMed ID: 18632808
[TBL] [Abstract][Full Text] [Related]
32. [Stabilization of 99m Tc-HMPAO with methylene blue: its use in leukocyte labelling)].
García Seguí V; Roca Engroñat M; Armero Muñoz F; Iglesias Allende F; Gomes Barreto de Mélo V; Martin-Comín J
Rev Esp Med Nucl; 1998; 17(4):261-4. PubMed ID: 9721341
[TBL] [Abstract][Full Text] [Related]
33. Targeting of 111In-labeled dendritic cell human vaccines improved by reducing number of cells.
Aarntzen EH; Srinivas M; Bonetto F; Cruz LJ; Verdijk P; Schreibelt G; van de Rakt M; Lesterhuis WJ; van Riel M; Punt CJ; Adema GJ; Heerschap A; Figdor CG; Oyen WJ; de Vries IJ
Clin Cancer Res; 2013 Mar; 19(6):1525-33. PubMed ID: 23382117
[TBL] [Abstract][Full Text] [Related]
34. Targeting monocytes and macrophages by means of SPECT and PET.
Van De Wiele C; Sathekge M; Maes A
Q J Nucl Med Mol Imaging; 2014 Sep; 58(3):269-75. PubMed ID: 24844256
[TBL] [Abstract][Full Text] [Related]
35. A comparative study of 99Tcm-d,l-HMPAO and 99Tcm-d,l-CBPAO as leukocyte-labelling agents.
Tsai CS; Kao CH; Yeh SJ; Wang SJ
Nucl Med Commun; 1996 Jan; 17(1):76-9. PubMed ID: 8692477
[TBL] [Abstract][Full Text] [Related]
36. Labeled granulocyte scanning for the diagnosis of infected necrosis in acute pancreatitis: what kind of labeling should be used?
Heresbach D; Devillers A; Rabot A; Moisan A; Malledant Y; Bourguet P; Bretagne JF; Gosselin M
Pancreas; 1996 May; 12(4):381-7. PubMed ID: 8740406
[TBL] [Abstract][Full Text] [Related]
37. Value of technetium-99m HMPAO-labelled leucocyte scintigraphy as an initial screening test in patients suspected of having inflammatory bowel disease.
Giaffer MH; Tindale WB; Holdsworth D
Eur J Gastroenterol Hepatol; 1996 Dec; 8(12):1195-200. PubMed ID: 8980940
[TBL] [Abstract][Full Text] [Related]
38. Measurement of the secretion of technetium-99m hexamethylpropylene amine oxime into breast milk.
Marshall DS; Newberry NR; Ryan PJ
Eur J Nucl Med; 1996 Dec; 23(12):1634-5. PubMed ID: 8929318
[TBL] [Abstract][Full Text] [Related]
39. 111In-oxine labelling of tumour-cytotoxic macrophages generated in vitro from circulating blood monocytes: an in vitro evaluation.
Marienhagen J; Hennemann B; Andreesen R; Eilles C
Nucl Med Commun; 1995 May; 16(5):357-61. PubMed ID: 7659388
[TBL] [Abstract][Full Text] [Related]
40. 99mTc-HM-PAO for leukocyte labeling--experimental comparison with 111In oxine in dogs.
McAfee JG; Subramanian G; Gagne G; Schneider RF; Zapf-Longo C
Eur J Nucl Med; 1987; 13(7):353-7. PubMed ID: 3123237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
